Nephrology Dialysis Transplantation

Papers
(The H4-Index of Nephrology Dialysis Transplantation is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration295
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA246
Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey134
Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls109
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics104
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D103
ADAM17 inhibition may exert a protective effect on COVID-1994
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion91
Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak81
High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients81
Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study77
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)73
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis67
Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center66
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)64
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice62
Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?61
COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study61
Targeting acute kidney injury in COVID-1957
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial54
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease52
Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism52
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort51
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone47
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)46
Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study45
The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury and/or proteinuria44
At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis44
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disea44
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAP44
Meaning of empowerment in peritoneal dialysis: focus groups with patients and caregivers42
Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players41
The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes41
Acute kidney injury in patients treated with anti-programmed death receptor-1 for advanced melanoma: a real-life study in a single-centre cohort40
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results39
Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management39
Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?38
Clinical and predictive value of simplified creatinine index used as muscle mass surrogate in end-stage kidney disease haemodialysis patients—results from the international MONitoring Dialysis Outcome38
0.090171813964844